Mandate

Vinge advises when Lendify, a digital lender and one of Sweden’s largest challengers to the banking sector, reaches a billion valuation in conjunction with new capital raising

September 10, 2019 M&A

Vinge has advised Lendify AB (publ) (”Lendify”) in connection with the procurement of new capital in an investment round in a total amount of approximately SEK 197 million.

The issue occurs to a valuation of Lendify of approximately SEK 1 billion (prior to the investment). The capital is intended to be used for capital adequacy and future liquidity.

Vinge’s team primarily consisted of partner Jonas Johansson together with, among others, associates Filip Öhrner, Anna Thoms and Hanna Risberg.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025